Zvast-Bio Pharmaceutical company z-bio 2021-01-15 1408

　　On the morning of January 13, 2021, Lei Dongshui, Director of the Standing Committee of the Dongxiang District People’s Congress, Zhang Zhihui, Deputy Director, and Zhang Donghua, Director of the Office, visited Zvast-Bio for inspection. They were received by Zvast-Bio General Manager Jiang Bin, Technical Center Director Xiong Zhongxian, and Sales Center Operations Director Wang Junping The grand reception.

General manager Mr. Jiang Bin introduced the development status of our company to Director Lei and his party.

　　The general manager of Zvast-Bio Jiang Bin focused on introducing the development status of the company to Director Lei and his party: Jiangxi Zvast-Bio Biotechnology Co., Ltd. is a national high-tech enterprise integrating life science research technology and drug R&D CRO support. The track where Zvast-Bio is located serves life science research technology and a drug research and development CRO centered on model animals. With the company’s strong R&D technical team and the number of domestically leading animal models, it is in the field of life science technology research and CRO Has a significant influence.。

General manager Mr. Jiang Bin was making a speech.

Zvast-Bio responded to the call of the Party Central Committee to strengthen the hard core of science and technology. Aiming at the weak links of domestic disease animal models, it invested a large amount of funds for basic research and development. It has prepared more than 150 disease animal models and has become one of the top domestic companies in preparing disease animal models. The 2020 new coronavirus epidemic has made more scientists re-recognize the new value of disease animal models. As an indispensable supporting condition for the development of industries such as life science research and biomedicine research and development, countries are constantly developing, establishing and improving various animal models of diseases. The demand for the types and quantity of disease animal models in pharmaceutical research companies and scientific research fields will show a trend of continuous rapid growth. Based on the knowledge-intensive, talent-intensive, and capital-intensive characteristics of the industry,Zvast-Bio has established a high-level talent echelon, with 7 core team members and more than 150 full-time employees, including 4 doctors and more than 40 masters. The overall talent qualifications are The level is at the leading level in Jiangxi, and a research and development team with returnees as academic leaders has been formed. The talent structure, professional combination, and division of responsibilities are very reasonable.

　　Zvast-Bio is based in Jiangxi, with business facing the whole country, and has three core advantages:

　　 1. There are 150 kinds of disease animal models, which are increasing at a rate of 30-50 kinds every year, making it the best in the country.

　　 2. An industrial chain centered on model animals has been formed.

　　3. Established Zvast-Bio's own standardization and management system.

　　 With the support of governments at all levels, Zvast-Bio has won the following honors: National High-tech Enterprise, "Experimental Animal Use Permit" issued by Jiangxi Science and Technology Department, member unit of Chinese Society of Laboratory Animals, governing unit of Jiangxi Society of Laboratory Animals. Zvast-Bio and Nanchang University, Jiangxi University of Finance and Economics, Jiangxi Agricultural University and other units have established educational practice bases to ensure the company's advanced R&D technology and leadership in talent training.

　　 General Manager Jiang Bin finally said: With the continuous increase in the types of animal model preparations, Zvast-Bio requires more and more laboratory construction space, and the application of development land has also been the top priority of our corporate planning in recent years. Although starting a business abroad, he will always pay attention to the development and construction of his hometown. In the future, he hopes to better build his hometown and give back to his hometown. He also hopes to strengthen cooperation between enterprises and the government and contribute more to the prosperity and development of his hometown.

Director Lei thinks that we can fill the gap of technological upgrading in Dongxiang District.

        Lei believes that: Dongxiang District currently attracts investment mainly from the real economy, and there are few research-oriented enterprises. As a technology service enterprise, Zvast-Bio can fill the gap in technology upgrading in Dongxiang District, and there is a lot of room for development in the future.

　　 Afterwards, the two parties had an important conversation on land for enterprise development, talent introduction, corporate taxation, development planning, and laboratory construction needs.

Visiting our laboratory research platform

The development course of  Zvast-Bio.

　　Director Lei, accompanied by Director Xiong of Zvast-Bioechnology Center, visited the laboratory scientific research platform and showed the development history of Zvast-Bio.